These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4248531)

  • 1. [Studies on the process of fibrinogen breakdown by plasmin. II. Relationship between serial thrombin time and plasma antithrombin or antiplasmin].
    Shinada S
    Nihon Naika Gakkai Zasshi; 1970 Sep; 59(9):959-66. PubMed ID: 4248531
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation studies of the vascular intima. II. Antithrombin activity.
    Oe K
    Nihon Ketsueki Gakkai Zasshi; 1969 Apr; 32(2):297-310. PubMed ID: 5388239
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
    Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
    Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
    [No Abstract]   [Full Text] [Related]  

  • 5. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.
    Collen D; De Cock F
    Thromb Res; 1975 Jul; 7(1):235-8. PubMed ID: 125465
    [No Abstract]   [Full Text] [Related]  

  • 7. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for antiplasmin activity determination.
    Wolosowicz N; Prokopowicz J
    Haematologia (Budap); 1971; 5(3):293-9. PubMed ID: 4256875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Technics for the study of the blood coagulation and fibrinolytic system].
    Lasch HG; Heene D
    Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systems.
    Collen D
    Acta Clin Belg; 1977; 32(6):398-402. PubMed ID: 151470
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M; Arnesen H; Godal HC
    Thromb Diath Haemorrh; 1973 Jun; 29(3):592-7. PubMed ID: 4271546
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between blood coagulation and thrombosis and atherosclerosis in man, monkeys and carnivores.
    Hawkey CM
    Thromb Diath Haemorrh; 1974 Mar; 31(1):103-18. PubMed ID: 4209392
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of thrombin time, activities of antithrombin II and 3 following administration of cobalt (II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Z Gesamte Inn Med; 1968 Sep; 23(17):537-9. PubMed ID: 5715725
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.
    Nowak-Göttl U; Rath B; Binder M; Hassel JU; Wolff J; Husemann S; Ritter J
    Haematologica; 1995; 80(5):451-3. PubMed ID: 8566890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.